Sarocladium strictum
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Summary
Sarocladium strictum is an extract from Sarocladium strictum used in allergy testing.
- Generic Name
- Sarocladium strictum
- DrugBank Accession Number
- DB14168
- Background
Sarocladium strictum allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Acremonium strictum allergenic extract
- Acremonium strictum extract
- Ae-cephalosporium acrimonium
- Allergenic extract- cephalosporium acremonium
- Allergenic extract, cephalosporium acremonium
- Allergenic extract, cephalosporium acrimonium
- Cephalosporium chrysogenum thirum. & sukapure 1963
- Molds, rusts and smuts, acremonium strictum
- Molds, rusts and smuts, cephalosporium acremonium
- Sarocladium strictum
Pharmacology
- Indication
Used in allergenic testing.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Acremonium strictum Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Acremonium strictum Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Acremonium strictum Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Acremonium strictum Solution 0.001 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Acremonium strictum Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image New Stock Fungi Mix Sarocladium strictum (0.003125 g/1mL) + Alternaria alternata (0.003125 g/1mL) + Aspergillus niger var. niger (0.003125 g/1mL) + Aureobasidium pullulans var. pullutans (0.003125 g/1mL) + Botrytis cinerea (0.003125 g/1mL) + Candida albicans (0.003125 g/1mL) + Chaetomium globosum (0.003125 g/1mL) + Cladosporium sphaerospermum (0.003125 g/1mL) + Cochliobolus sativus (0.003125 g/1mL) + Epicoccum nigrum (0.003125 g/1mL) + Gibberella fujikuroi (0.003125 g/1mL) + Mucor plumbeus (0.003125 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.003125 g/1mL) + Pleospora betae (0.003125 g/1mL) + Rhizopus stolonifer (0.003125 g/1mL) + Trichophyton mentagrophytes (0.003125 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US New Stock Fungi Mix Sarocladium strictum (1250 [PNU]/1mL) + Alternaria alternata (1250 [PNU]/1mL) + Aspergillus niger var. niger (1250 [PNU]/1mL) + Aureobasidium pullulans var. pullutans (1250 [PNU]/1mL) + Botrytis cinerea (1250 [PNU]/1mL) + Candida albicans (1250 [PNU]/1mL) + Chaetomium globosum (1250 [PNU]/1mL) + Cladosporium sphaerospermum (1250 [PNU]/1mL) + Cochliobolus sativus (1250 [PNU]/1mL) + Epicoccum nigrum (1250 [PNU]/1mL) + Gibberella fujikuroi (1250 [PNU]/1mL) + Mucor plumbeus (1250 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (1250 [PNU]/1mL) + Pleospora betae (1250 [PNU]/1mL) + Rhizopus stolonifer (1250 [PNU]/1mL) + Trichophyton mentagrophytes (1250 [PNU]/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US New Stock Fungi Mix Sarocladium strictum (0.00625 g/1mL) + Alternaria alternata (0.00625 g/1mL) + Aspergillus niger var. niger (0.00625 g/1mL) + Aureobasidium pullulans var. pullutans (0.00625 g/1mL) + Botrytis cinerea (0.00625 g/1mL) + Candida albicans (0.00625 g/1mL) + Chaetomium globosum (0.00625 g/1mL) + Cladosporium sphaerospermum (0.00625 g/1mL) + Cochliobolus sativus (0.00625 g/1mL) + Epicoccum nigrum (0.00625 g/1mL) + Gibberella fujikuroi (0.00625 g/1mL) + Mucor plumbeus (0.00625 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.00625 g/1mL) + Pleospora betae (0.00625 g/1mL) + Rhizopus stolonifer (0.00625 g/1mL) + Trichophyton mentagrophytes (0.00625 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US New Stock Fungi Mix Sarocladium strictum (0.0000625 g/1mL) + Alternaria alternata (0.0000625 g/1mL) + Aspergillus niger var. niger (0.0000625 g/1mL) + Aureobasidium pullulans var. pullutans (0.0000625 g/1mL) + Botrytis cinerea (0.0000625 g/1mL) + Candida albicans (0.0000625 g/1mL) + Chaetomium globosum (0.0000625 g/1mL) + Cladosporium sphaerospermum (0.0000625 g/1mL) + Cochliobolus sativus (0.0000625 g/1mL) + Epicoccum nigrum (0.0000625 g/1mL) + Gibberella fujikuroi (0.0000625 g/1mL) + Mucor plumbeus (0.0000625 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0000625 g/1mL) + Pleospora betae (0.0000625 g/1mL) + Rhizopus stolonifer (0.0000625 g/1mL) + Trichophyton mentagrophytes (0.0000625 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US New Stock Fungi Mix Sarocladium strictum (0.003125 g/1mL) + Alternaria alternata (0.003125 g/1mL) + Aspergillus niger var. niger (0.003125 g/1mL) + Aureobasidium pullulans var. pullutans (0.003125 g/1mL) + Botrytis cinerea (0.003125 g/1mL) + Candida albicans (0.003125 g/1mL) + Chaetomium globosum (0.003125 g/1mL) + Cladosporium sphaerospermum (0.003125 g/1mL) + Cochliobolus sativus (0.003125 g/1mL) + Epicoccum nigrum (0.003125 g/1mL) + Gibberella fujikuroi (0.003125 g/1mL) + Mucor plumbeus (0.003125 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.003125 g/1mL) + Pleospora betae (0.003125 g/1mL) + Rhizopus stolonifer (0.003125 g/1mL) + Trichophyton mentagrophytes (0.003125 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3F36V0451W
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Injection, solution Percutaneous 0.10 g/1mL Injection, solution Subcutaneous 10000 [PNU]/1mL Injection, solution Subcutaneous 20000 [PNU]/1mL Injection, solution Subcutaneous 40000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 0.025 g/1mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.1 g/1mL Injection, solution Percutaneous; Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at June 29, 2018 22:01 / Updated at June 12, 2020 16:53